![Denil Shekhat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 21 192 $ al 30/06/2026
Dr. Denil N.
Shekhat, MD, is an Independent Director at MIRA Pharmaceuticals, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. He received his undergraduate degree from Bowdoin College and a doctorate degree from The University of Tennessee Health Science Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2026 | 22.378 ( 0,05 % ) | 21 192 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 13/03/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
 The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
